Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003407
Status:
WITHDRAWN
Last Update Posted:
2023-02-02
First Post:
1999-11-01
Brief Title:
Amifostine High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Sponsor:
Rush University Medical Center
Organization:
Rush University Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neutropenia |
| DrugAgent Toxicity by TissueOrgan |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| neutropenia | View |
| recurrent adult acute myeloid leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| untreated adult acute myeloid leukemia | View |
| refractory anemia with excess blasts in transformation | View |
| secondary acute myeloid leukemia | View |
| de novo myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| drugagent toxicity by tissueorgan | View |